Novo Nordisk expands lawsuits against weight-loss drug compounders | ReutersAugust 5, 2025#glp1-agonist#Novo-Nordisk#lawsuits#compounding-pharmacy#backfilled#compounding·reuters.com·Aug 8, 2025Novo Nordisk expands lawsuits against weight-loss drug compounders | Reuters
A new chapter for online sales of obesity drug alternatives test legal llimitsJune 16, 2025#telehealth#compounding-pharmacy#glp1-agonist#backfilled#compounding·npr.org·Jun 17, 2025A new chapter for online sales of obesity drug alternatives test legal llimits
Empower Pharmacy allegedly used low-quality ingredients, skirted rules (requires free login)May 15, 2025#compounding-pharmacy#503B#glp1-agonist#Empower#Texas#backfilled#compounding·endpts.com·May 16, 2025Empower Pharmacy allegedly used low-quality ingredients, skirted rules (requires free login)
Warning Letter Tailstorm Health Inc. dba Medivant Health MARC-CMS 703497April 8, 2025#FDA#Warning-letters#compounding-pharmacy#503B#glp1-agonist#Arizona#backfilled#compounding·fda.gov·May 14, 2025Warning Letter Tailstorm Health Inc. dba Medivant Health MARC-CMS 703497
Lilly sues four compounders over copies of weight-loss drugsApril 23, 2025#Eli-Lilly#tirzepatide#compounding-pharmacy#lawsuits#California#glp1-agonist#backfilled#compounding·finance.yahoo.com·Apr 23, 2025Lilly sues four compounders over copies of weight-loss drugs
Lilly sues two compounders over copies of weight-loss drugsApril 1, 2025#Eli-Lilly#tirzepatide#glp1-agonist#compounding-pharmacy#backfilled#compounding·reuters.com·Apr 1, 2025Lilly sues two compounders over copies of weight-loss drugs
A website sold patients obesity drugs at affordable rates. Now they're paying the priceFebruary 8, 2025#compounding-pharmacy#glp1-agonist#telehealth#Florida#backfilled#compounding·npr.org·Feb 10, 2025A website sold patients obesity drugs at affordable rates. Now they're paying the price
We're reading about China probe of AstraZeneca, a Super Bowl ad | STATFebruary 6, 2025#PSM#compounding-pharmacy#glp1-agonist#Hims&Hers#backfilled#compounding·statnews.com·Feb 7, 2025We're reading about China probe of AstraZeneca, a Super Bowl ad | STAT
Warning Letter ProRx, LLC - MARCS-CMS 696742December 20, 2024#compounding-pharmacy#Warning-letters#FDA#semaglutide#tirzepatide#vancomycin#tobramycin#glp1-agonist#backfilled#compounding·fda.gov·Jan 29, 2025Warning Letter ProRx, LLC - MARCS-CMS 696742
Laughlin pharmacists put on probation after dispensing faulty weight loss drugs; changes promised | News | mohavedailynews.comJanuary 15, 2025#Nevada#Arizona#glp1-agonist#compounding-pharmacy#Compounding#backfilled#compounding·mohavedailynews.com·Jan 17, 2025Laughlin pharmacists put on probation after dispensing faulty weight loss drugs; changes promised | News | mohavedailynews.com
Louisville pharmacy dispensing compounded weight loss drugs in effort to address shortage | News from WDRB | wdrb.comJanuary 16, 2025#glp1-agonist#Kentucky#Compounding#compounding-pharmacy#backfilled#compounding·wdrb.com·Jan 17, 2025Louisville pharmacy dispensing compounded weight loss drugs in effort to address shortage | News from WDRB | wdrb.com
Inside the telehealth-fueled GLP-1 alternative marketNovember 26, 2024#drug-shortages#glp1-agonist#telehealth#compounding-pharmacy#backfilled#compounding·statnews.com·Nov 26, 2024Inside the telehealth-fueled GLP-1 alternative market
As Eli Lilly, compounders battle over weight loss drugs, patients may lose outOctober 11, 2024#Eli-Lilly#compounding-pharmacy#Mounjaro#Zepbound#tirzepatide#glp1-agonist#backfilled#compounding·statnews.com·Oct 11, 2024As Eli Lilly, compounders battle over weight loss drugs, patients may lose out
Trizepatide shortage resolved? FDA says yes, Compounders say noOctober 7, 2024#FDA#compounding-pharmacy#drug-shortages#tirzepatide#glp1-agonist#backfilled#compounding·medscape.com·Oct 8, 2024Trizepatide shortage resolved? FDA says yes, Compounders say no
Compounding pharmacies caught in counterfeit controversySeptember 27, 2024#compounding-pharmacy#glp1-agonist#Ozempic#Wegovy#Novo-Nordisk#backfilled#compounding·finance.yahoo.com·Sep 27, 2024Compounding pharmacies caught in counterfeit controversy
Enforcement Report - Revive Rx LLCApril 20, 2024#glp1-agonist#compounding-pharmacy#tirzepatide#Texas#backfilled#compounding·accessdata.fda.gov·Sep 19, 2024Enforcement Report - Revive Rx LLC
'Joe Rogan' guest who ripped FDA sees mail-order pharmacy ReviveRx caught up in embarrassing recallSeptember 18, 2024#compounding-pharmacy#glp1-agonist#testerone#Texas#recalls#backfilled#compounding·nypost.com·Sep 19, 2024'Joe Rogan' guest who ripped FDA sees mail-order pharmacy ReviveRx caught up in embarrassing recall
Telehealth giant Hims & Hers faces hurdles with compounded GLP-1 drugsAugust 29, 2024#glp1-agonist#Compounding#compounding-pharmacy#semaglutide#tirzepatide#liraglutide#Hims&Hers#backfilled#compounding·statnews.com·Sep 3, 2024Telehealth giant Hims & Hers faces hurdles with compounded GLP-1 drugs
A scientist tested knock-off Ozempic sold online. He found dangerous ingredients and doses — and got scammed out of money. - Business Insider IndiaAugust 17, 2024#semaglutide#Ozempic#compounding-pharmacy#Tim-Mackey#glp1-agonist#backfilled#compounding·businessinsider.in·Aug 19, 2024A scientist tested knock-off Ozempic sold online. He found dangerous ingredients and doses — and got scammed out of money. - Business Insider India
Rising popularity of counterfeit weight-loss drugs raises concernsAugust 16, 2024#op-ed#glp1-agonist#compounding-pharmacy#backfilled#compounding·thehill.com·Aug 19, 2024Rising popularity of counterfeit weight-loss drugs raises concerns
Eli Lilly takes action over Zepbound, Mounjaro copycatsAugust 15th, 2024#glp1-agonist#Zepbound#Mounjaro#United-States#compounding-pharmacy#backfilled#compounding·beckershospitalreview.com·Aug 19, 2024Eli Lilly takes action over Zepbound, Mounjaro copycats
The Ozempic Shortage Is Over - The AtlanticAugust 16, 2024#Ozempic#glp1-agonist#compounding-pharmacy#backfilled#compounding·theatlantic.com·Aug 16, 2024The Ozempic Shortage Is Over - The Atlantic
It’s shockingly easy to buy off-brand Ozempic online, even if you don’t need itJuly 12, 2024#compounding-pharmacy#glp1-agonist#Ozempic#backfilled#compounding·wired.com·Jul 15, 2024It’s shockingly easy to buy off-brand Ozempic online, even if you don’t need it
‘Compounded’ weight-loss drugs are a growing problem for state regulatorsJuly 8, 2024#compounding-pharmacy#weight-loss#glp1-agonist#backfilled#compounding·newjerseymonitor.com·Jul 9, 2024‘Compounded’ weight-loss drugs are a growing problem for state regulators
Why counterfeit Ozempic is a global-growth industryJune 4, 2024#glp1-agonist#Ozempic#Wegovy#counterfeit-injections#United-States#organized-crime#patient-harm#Illinois#compounding-pharmacy#backfilled#compounding·vanityfair.com·Jun 4, 2024Why counterfeit Ozempic is a global-growth industry
ACA Pharmacy made imitation Ozempic and Mounjaro. Then it went bust. - The Washington PostJanuary 15, 2024#tirzepatide#compounding-pharmacy#glp1-agonist#inspections#backfilled#compounding·washingtonpost.com·Jan 15, 2024ACA Pharmacy made imitation Ozempic and Mounjaro. Then it went bust. - The Washington Post
Wegovy maker Novo Nordisk sues Florida pharmacies over copycat drugsJuly 7, 2023#semaglutide#Florida#compounding-pharmacy#glp1-agonist#backfilled#compounding·reuters.com·Jul 10, 2023Wegovy maker Novo Nordisk sues Florida pharmacies over copycat drugs
More than 200 deaths linked to weight-loss jabs, health agency suggestsAugust 6, 2026#tirzepatide#death#MHRA#weight-loss#glp1-agonist#United-Kingdom#backfilled·telegraph.co.uk·Aug 10, 2026More than 200 deaths linked to weight-loss jabs, health agency suggests
Slim Shady: Smugglers Eye Big Profits Running Weight Loss Drugs into BrazilJuly 31, 2026July 31, 2026#Brazil#Paraguay#tirzepatide#Mounjaro#black-market#glp1-agonist#backfilled·occrp.org·Aug 3, 2026Slim Shady: Smugglers Eye Big Profits Running Weight Loss Drugs into Brazil
New Life Pharma LLC - 725661 - 04/14/2026 | FDAApril 14, 2026#FDA#Warning-letters#semaglutide#tirzepatide#unapproved-drugs#med-spas#glp1-agonist#backfilled·fda.gov·Apr 23, 2026New Life Pharma LLC - 725661 - 04/14/2026 | FDA